-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Centessa Pharmaceuticals plc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q2 2025.
- Centessa Pharmaceuticals plc Operating Income (Loss) for the quarter ending June 30, 2025 was -$54.7M, a 24.3% decline year-over-year.
- Centessa Pharmaceuticals plc Operating Income (Loss) for the twelve months ending June 30, 2025 was -$206M, a 32.8% decline year-over-year.
- Centessa Pharmaceuticals plc annual Operating Income (Loss) for 2024 was -$201M, a 17.4% decline from 2023.
- Centessa Pharmaceuticals plc annual Operating Income (Loss) for 2023 was -$171M, a 19.3% increase from 2022.
- Centessa Pharmaceuticals plc annual Operating Income (Loss) for 2022 was -$212M, a 43.3% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)